Identification of blood protein biomarkers that aid in the clinical assessment of patients with malignant glioma

International Journal of Oncology

Volumn 40, Issue 6, 2012, Pages 1995-2003

  Xu, Baogang J ^a,b,c   An, Qi A ^a   Gowda, Supriya Srinivasa ^a   Yan, Wenwei ^c   Pierce, Larry A ^a   Abel, Ty W ^a,b   Rush, Sarah Z ^a   Cooper, Michael K ^a,b   Ye, Fei ^a   Shyr, Yu ^a,b   Weaver, Kyle D ^a,b   Thompson, Reid C ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarkers; Malignant glioma; Plasma; Prognosis; Proteomics; Serum

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN C3; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 7; BRAIN DERIVED NEUROTROPHIC FACTOR; CA 19-9 ANTIGEN; COMPLEMENT COMPONENT C3; ENDOTHELIN 1; FIBRINOGEN; GELATINASE A; IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 16; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; STEM CELL FACTOR; STROMELYSIN; THYROXINE BINDING GLOBULIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; BLOOD; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SURVIVAL; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SURVIVAL;

ADULT; AGED; BLOOD PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHEMOKINE CCL3; COHORT STUDIES; FEMALE; GENE EXPRESSION; GLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM GRADING; ROC CURVE; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84861775751     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1355     Document Type: Article

References (37)

1. Gerstner ER and Fine RL: Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm. J Clin Oncol 25: 2306-2312, 2007.
2. Quaranta M, Divella R, Daniele A, et al: Epidermal growth factor receptor serum levels and prognostic value in malignant gliomas. Tumori 93: 275-280, 2007. (Pubitemid 47080014)
3. Ilzecka J and Ilzecki M: APRIL is increased in serum of patients with brain glioblastoma multiforme. Eur Cytokine Netw 17: 276-280, 2006.
4. Brommeland T, Rosengren L, Fridlund S, Hennig R and Isaksen V: Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas. Acta Neurol Scand 116: 380-384, 2007. (Pubitemid 350045499)
5. Lin Y, Jiang T, Zhou K, et al: Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas. Neuro Oncol 11: 468-476, 2009.
6. Amonkar SD, Bertenshaw GP, Chen TH, et al: Development and preliminary evaluation of a multivariate index assay for ovarian cancer. PLoS One 4: e4599, 2009.
7. Rush SZ, Abel TW, Valadez JG, Pearson M and Cooper MK: Activation of the Hedgehog pathway in pilocytic astrocytomas. Neuro Oncol 12: 790-798, 2010.
8. Su Y, Shrubsole MJ, Ness RM, et al: Immunohistochemical expressions of Ki-67, cyclin D1, beta-catenin, cyclooxygenase-2, and epidermal growth factor receptor in human colorectal adenoma: a validation study of tissue microarrays. Cancer Epidemiol Biomarkers Prev 15: 1719-1726, 2006. (Pubitemid 44497109)
9. Ponten F, Jirstrom K and Uhlen M: The Human Protein Atlas - a tool for pathology. J Pathol 216: 387-393, 2008.
10. Ishii N, Tada M, Sakuma S, Sawamura Y, Shinohe Y and Abe H: Human astrocytoma cells are capable of producing macrophage inflammatory protein-1beta. J Neurooncol 37: 17-23, 1998. (Pubitemid 28073571)
11. Terpos E, Politou M, Viniou N and Rahemtulla A: Significance of macrophage inflammatory protein-1 alpha (MIP-1alpha) in multiple myeloma. Leuk Lymphoma 46: 1699-1707, 2005. (Pubitemid 43203102)
12. Lentzsch S, Gries M, Janz M, Bargou R, Dorken B and Mapara MY: Macrophage inflammatory protein 1-alpha (MIP-1 alpha) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells. Blood 101: 3568-3573, 2003. (Pubitemid 36857943)
13. Kumar R, Kamdar D, Madden L, et al: Th1/Th2 cytokine imbalance in meningioma, anaplastic astrocytoma and glioblastoma multiforme patients. Oncol Rep 15: 1513-1516, 2006.
14. Dummer W, Becker JC, Schwaaf A, Leverkus M, Moll T and Brocker EB: Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma. Melanoma Res 5: 67-68, 1995.
15. Shibata M, Nezu T, Kanou H, Abe H, Takekawa M and Fukuzawa M: Decreased production of interleukin-12 and type 2 immune responses are marked in cachectic patients with colorectal and gastric cancer. J Clin Gastroenterol 34: 416-420, 2002. (Pubitemid 34258317)
16. Smith ER, Zurakowski D, Saad A, Scott RM and Moses MA: Urinary biomarkers predict brain tumor presence and response to therapy. Clin Cancer Res 14: 2378-2386, 2008. (Pubitemid 351551071)
17. Girolamo F, Virgintino D, Errede M, et al: Involvement of metalloprotease- 2 in the development of human brain micro-vessels. Histochem Cell Biol 122: 261-270, 2004. (Pubitemid 39371495)
18. Chintala SK, Ali-Osman F, Mohanam S, et al: Effect of cisplatin and BCNU on MMP-2 levels in human glioblastoma cell lines in vitro. Clin Exp Metastasis 15: 361-367, 1997. (Pubitemid 27285809)
19. Hlobilkova A, Ehrmann J, Knizetova P, Krejci V, Kalita O and Kolar Z: Analysis of VEGF, Flt-1, Flk-1, nestin and MMP-9 in relation to astrocytoma pathogenesis and progression. Neoplasma 56: 284-290, 2009.
20. Norden AD, Drappatz J and Wen PY: Antiangiogenic therapies for high-grade glioma. Nat Rev Neurol 5: 610-620, 2009.
21. Zagzag D, Salnikow K, Chiriboga L, et al: Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain. Lab Invest 85: 328-341, 2005. (Pubitemid 40333150)
22. Yamamoto M, Ikeda K, Ohshima K, Tsugu H, Kimura H and Tomonaga M: Increased expression of low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor in human malignant astrocytomas. Cancer Res 57: 2799-2805, 1997. (Pubitemid 27283795)
23. Demeule M, Currie JC, Bertrand Y, et al: Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2. J Neurochem 106: 1534-1544, 2008.
24. Duffy MJ: CA 19-9 as a marker for gastrointestinal cancers: a review. Ann Clin Biochem 35: 364-370, 1998.
25. Andrijevic L: The influence of 8-Cl-cAMP on tumor marker CA19.9 on experimental glioma in rats. Arch Oncol 9: 9-12, 2001.
26. Ray P, Krishnamoorthy N and Ray A: Emerging functions of c-kit and its ligand stem cell factor in dendritic cells: regulators of T cell differentiation. Cell Cycle 7: 2826-2832, 2008.
27. Berdel WE, de Vos S, Maurer J, et al: Recombinant human stem cell factor stimulates growth of a human glioblastoma cell line expressing c-kit protooncogene. Cancer Res 52: 3498-3502, 1992.
28. Sun L, Hui AM, Su Q, et al: Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9: 287-300, 2006.
29. Tehrani M, Friedman TM, Olson JJ and Brat DJ: Intravascular thrombosis in central nervous system malignancies: a potential role in astrocytoma progression to glioblastoma. Brain Pathol 18: 164-171, 2008. (Pubitemid 351430394)
30. Guan M, Jin J, Su B, Liu WW and Lu Y: Tissue factor expression and angiogenesis in human glioma. Clin Biochem 35: 321-325, 2002. (Pubitemid 34804904)
31. Yamashita U and Kuroda E: Regulation of macrophage-derived chemokine (MDC, CCL22) production. Crit Rev Immunol 22: 105-114, 2002. (Pubitemid 35244753)
32. Maru SV, Holloway KA, Flynn G, et al: Chemokine production and chemokine receptor expression by human glioma cells: role of CXCL10 in tumour cell proliferation. J Neuroimmunol 199: 35-45, 2008.
33. Maurer M and von Stebut E: Macrophage inflammatory protein-1. Int J Biochem Cell Biol 36: 1882-1886, 2004. (Pubitemid 38760018)
34. Kouno J, Nagai H, Nagahata T, et al: Up-regulation of CC chemokine, CCL3L1, and receptors, CCR3, CCR5 in human glioblastoma that promotes cell growth. J Neurooncol 70: 301-307, 2004. (Pubitemid 40057958)
35. Wrensch M, Wiencke JK, Wiemels J, et al: Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res 66: 4531-4541, 2006.
36. Liebrich M, Guo LH, Schluesener HJ, et al: Expression of interleukin-16 by tumor-associated macrophages/activated microglia in high-grade astrocytic brain tumors. Arch Immunol Ther Exp (Warsz) 55: 41-47, 2007. (Pubitemid 46294892)
37. Shimizu K, Adachi K and Teramoto A: Growth hormone enhances natural killer cell activity against glioma. J Nippon Med Sch 72: 335-340, 2005. (Pubitemid 43098476)